Hydrochloric Acid

Hydrochloric Acid

SCHEMBL420241

Cl.O=C(O)c1cc(CO)nn1-c1ncccc1Cl

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC16A3 O15427 1/20 0.38
SLC16A1 P53985 1/20 0.38
MARS1 P56192 1/20 0.38
MALT1 Q9UDY8 2/20 0.37
LMNA P02545 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
GRN P28799 1/20 0.35
SORT1 Q99523 1/20 0.35
HIF1A Q16665 1/20 0.35
TRPA1 O75762 2/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
MYC P01106 1/20 0.34
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL957157 0.99 SLC16A3 (0.38) SLC16A3SLC16A1MARS1MALT1LMNA
SCHEMBL423980 0.99 SLC16A3 (0.39) SLC16A3SLC16A1MARS1MALT1LMNA
SCHEMBL13349718 0.90 SLC16A3 (0.36) SLC16A3SLC16A1MARS1MALT1TRPA1
SCHEMBL31060003 0.90 SLC16A3 (0.38) SLC16A3SLC16A1MARS1MALT1LMNA
SCHEMBL2039732 0.90 SLC16A3 (0.38) SLC16A3SLC16A1MARS1MALT1LMNA
SCHEMBL16014771 0.88 SLC16A3 (0.38) SLC16A3SLC16A1MARS1MALT1LMNA
SCHEMBL11928300 0.88 SLC16A3 (0.38) SLC16A3SLC16A1MARS1MALT1TRPA1
SCHEMBL13084792 0.88 SLC16A3 (0.40) SLC16A3SLC16A1MARS1MALT1GRN
SCHEMBL30233893 0.88 SLC16A3 (0.40) SLC16A3SLC16A1MARS1MALT1GRN
Hydrochloric Acid SCHEMBL959170 0.87 SLC16A3 (0.36) SLC16A3SLC16A1MALT1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9340526-B2 Process for preparing pyridyl-substituted pyrazoles BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-05-17 US disclosed
US-20150191447-A1 Process for Preparing Pyridyl-Substituted Pyrazoles BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-07-09 US disclosed
US-8987460-B2 Process for preparing pyridyl-substituted pyrazoles BAYER CROPSCIENCE AG (DE) 2015-03-24 US disclosed
CN-102482223-B Process for producing aryl-substituted pyrazoles BAYER CROPSCIENCE AG 2015-03-04 CN disclosed
EP-2414345-B1 Method for manufacturing Pyridyl-substituted pyrazoles BAYER CROPSCIENCE AG (DE) 2014-09-17 EP disclosed
EP-2456747-B1 Method for preparing alkoxyenones and enaminoketones BAYER CROPSCIENCE AG (DE) 2014-06-25 EP disclosed
EP-2456760-B1 Method for manufacturing aryl-substituted pyrazoles BAYER CROPSCIENCE AG (DE) 2014-05-07 EP disclosed
US-20130131347-A1 Process for Preparing Pyridyl-Substituted Pyrazoles BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-05-23 US disclosed
US-8399679-B2 Aryl-substituted pyrazoles BAYER CROPSCIENCE AG (DE) 2013-03-19 US disclosed
US-8362261-B2 Process for preparing pyridyl-substituted pyrazoles BAYER CROPSCIENCE AG (DE) 2013-01-29 US disclosed
EP-2456760-A1 PROCESS FOR PRODUCING ARYL-SUBSTITUTED PYRAZOLES Bayer CropScience AG (DE) 2012-05-30 EP disclosed
CN-102388033-A Process for preparing pyridyl-substituted pyrazoles BAYER CROPSCIENCE AG 2012-03-21 CN disclosed
EP-2414345-A1 METHOD FOR PRODUCING PYRIDYL-SUBSTITUTED PYRAZOLES Bayer CropScience AG (DE) 2012-02-08 EP disclosed
US-20120022285-A1 Novel alkoxy enones and enamino ketones and a process for preparation thereof BAYER CROPSCIENCE AG (DE) 2012-01-26 US disclosed
US-20110087029-A1 Process for Preparing Pyridyl-Substituted Pyrazoles BAYER CROPSCIENCE AG (DE) 2011-04-14 US disclosed
US-20110028729-A1 Process for preparing aryl-substituted pyrazoles BAYER CROPSCIENCE AG (DE) 2011-02-03 US disclosed
US-20110021782-A1 Novel alkoxy enones and enamino ketones and a process for preparation thereof BAYER CROPSCIENCE AG (DE) 2011-01-27 US disclosed
WO-2011009551-A1 PROCESS FOR PRODUCING ARYL-SUBSTITUTED PYRAZOLES BAYER CROPSCIENCE AG (DE) 2011-01-27 WO disclosed
EP-2243777-A1 Method for manufacturing Pyridyl-substituted pyrazoles Bayer CropScience AG (DE) 2010-10-27 EP disclosed
WO-2010112178-A1 METHOD FOR PRODUCING PYRIDYL-SUBSTITUTED PYRAZOLES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2010-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131347-A1 Process for Preparing Pyridyl-Substituted Pyrazoles PDXK, PLK2, WNK3 SLC16A3 1755/4885SLC16A1 2255/4885MARS1 3056/4885
US-20120022285-A1 Novel alkoxy enones and enamino ketones and a process for preparation thereof AKR7A2, CYP51A1, PDK3 SLC16A3 4068/4885SLC16A1 4722/4885MARS1 3091/4885
US-20110028729-A1 Process for preparing aryl-substituted pyrazoles WNK3, WNK2, TYR SLC16A3 3138/4885SLC16A1 4128/4885MARS1 3894/4885
US-20150191447-A1 Process for Preparing Pyridyl-Substituted Pyrazoles PDXK, PLK2, WNK3 SLC16A3 1755/4885SLC16A1 2255/4885MARS1 3056/4885
US-20110087029-A1 Process for Preparing Pyridyl-Substituted Pyrazoles PDXK, PLK2, WNK3 SLC16A3 1755/4885SLC16A1 2255/4885MARS1 3056/4885
US-20110021782-A1 Novel alkoxy enones and enamino ketones and a process for preparation thereof AKR7A2, CYP51A1, PDK3 SLC16A3 4068/4885SLC16A1 4722/4885MARS1 3091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.